NCT05753280View on ClinicalTrials.gov

Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Chronic Hepatitis b
Interventions
DRUG

Vitamin D

Patients take 800 mg vitamin D capsules daily during the whole treatment period

Trial Locations (1)

510630

Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT05753280 - Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB | Biotech Hunter | Biotech Hunter